Related Experiment Video
Updated: Jul 28, 2026
07:10
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Primary prophylaxis of variceal hemorrhage
1Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA. Robert.Lowe@bmc.org
Clinics in Liver Disease
|September 22, 2001
Summary
Primary prevention of esophageal variceal bleeding involves nonselective beta-blockers for medium/large varices, with dosage guided by heart rate or hepatic venous pressure gradient (HVPG). Small varices require observation, not endoscopic therapy.
Area of Science:
- Gastroenterology
- Hepatology
- Internal Medicine
Background:
- Esophageal variceal bleeding is a serious complication of portal hypertension.
- Pharmacologic therapy is the standard for primary prophylaxis.
- Current dosing targets for beta-blockers may not correlate well with portal pressure reduction.
Purpose of the Study:
- To outline an evidence-based algorithm for the primary prevention of variceal hemorrhage.
- To guide the use of pharmacologic therapy and monitoring for patients at risk.
Main Methods:
- Utilizes a nonselective beta-blocker for patients with medium or large varices.
- Dose titration aims for a 25% decrease in resting heart rate or a heart rate of 55-60 bpm.
- Hepatic venous pressure gradient (HVPG) measurement before and after 3 months of therapy guides effectiveness.
Main Results:
- Effective prophylaxis is indicated by a 20% decrease in HVPG or an HVPG < 12 mm Hg.
- If HVPG is not adequately lowered, a long-acting nitrate may be added.
- Patients with small varices should be monitored with endoscopy every 2 years.
Conclusions:
- Nonselective beta-blockers are recommended for primary prophylaxis in patients with medium/large varices.
- HVPG measurement provides a rational approach to drug dosing and assessing efficacy.
- Endoscopic therapy is not indicated for primary prevention of variceal bleeding.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...